Skip to main content

. 2022 May 17;11:29. doi: 10.1186/s40035-022-00306-0

Correction: Clinical outcome measures in dementia with Lewy bodies trials: critique and recommendations

Federico Rodriguez-Porcel ^1,^✉, Kathryn A Wyman-Chick ², Carla Abdelnour Ruiz ³, Jon B Toledo ⁴, Daniel Ferreira ^5,⁶, Prabitha Urwyler ⁷, Rimona S Weil ⁸, Joseph Kane ⁹, Andrea Pilotto ¹⁰, Arvid Rongve ^11,¹², Bradley Boeve ¹³, John-Paul Taylor ¹⁴, Ian McKeith ¹⁴, Dag Aarsland ¹⁵, Simon J G Lewis ¹⁶; the Lewy Body Dementias Clinical Trials Workgroup from the Lewy Body Dementias Professional Interest Area - Alzheimer’s Association International Society to Advance Alzheimer’s Research and Treatment (ISTAART)+

PMCID: PMC9112536 PMID: 35578366

Correction to: Translational Neurodegeneration (2022) 11:24 https://doi.org/10.1186/s40035-022-00299-w

Following publication of the original article [1], the authors identified some errors in the Additional files 1–5.

The original article [1] has been corrected.

Reference

1.Rodriguez-Porcel F, Wyman-Chick KA, Abdelnour Ruiz C, et al. Clinical outcome measures in dementia with Lewy bodies trials: critique and recommendations. Transl Neurodegener. 2022;11:24. doi: 10.1186/s40035-022-00299-w. [DOI] [PMC free article] [PubMed] [Google Scholar]

ACTIONS

RESOURCES